- CSR Summary Not Yet Available
- NCT02431247 Not Available
- Primary Citation
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameDarunavirProduct NamePREZISTA®Therapeutic AreaViral DiseasesEnrollment725% Female11.70%%% White71.40%%
Product ClassAntiviral AgentSponsor Protocol NumberTMC114FD2HTX3001 - WK48Data PartnerJohnson & JohnsonCondition StudiedHIV InfectionsMean/Median Age (Years)34
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available